United States· US:0173-0927_a34e2ed2-aeb5-4d39-a44c-6996a763e4de
Exdensur
A medicinal product containing depemokimab, registered in United States by GlaxoSmithKline LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- depemokimab
- Manufacturer
- GlaxoSmithKline LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 2
- ndc1101730927421 SYRINGE in 1 CARTON (0173-0927-42) / 1 mL in 1 SYRINGE
- ndc1101730927611 SYRINGE in 1 CARTON (0173-0927-61) / 1 mL in 1 SYRINGE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Depemokimab in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumExdensur 100 mgGlaxoSmithKline Trading Services
- CzechiaEXDENSURGlaxoSmithKline Trading Services Limited, Dublin
- SpainEXDENSUR 100 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAGlaxosmithkline Trading Services Limited
- FinlandEXDENSURGlaxoSmithKline Trading Services Limited
- United KingdomExdensur 100mg/1ml solution for injection pre-filled pensGlaxoSmithKline UK Ltd
- IrelandEXDENSUR 100 mg solution for injection in pre-filled penGlaxoSmithKline Trading Services Limited
- IcelandEXDENSURGlaxoSmithKline Trading Services Limited
- Japanデペモキマブ（遺伝子組換え）グラクソ・スミスクライン
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Exdensur
- Liechtenstein · Exdensur
- Norway · Exdensur
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/95fef748-a6c3-447d-a393-f429d442d564 GET /v1/drugs/95fef748-a6c3-447d-a393-f429d442d564?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": null
},
"productid": "0173-0927_a34e2ed2-aeb5-4d39-a44c-6996a763e4de",
"productndc": "0173-0927",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "DEPEMOKIMAB",
"proprietary_name": "Exdensur",
"active_ingred_unit": "mg/mL",
"application_number": "BLA761458",
"marketing_category": "BLA",
"nonproprietary_name": "depemokimab",
"start_marketing_date": "20251216",
"active_numerator_strength": "100"
}See everything about depemokimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.